18 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
#Management # ... Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
ACEI Antihypertensive Dose Comparison. Consider divided (BID) regimen for better pre-dose (trough) BP control for the
potassium, and renal ... ACEInhibitor #ACEIs #Dosing ... #Conversion #Pharmacology ... #Hypertension #Management ... PrimaryCare #Comparison #Table
Pharmacology of diuretics

Acetazolamide, Loop diuretics, Thiazide‐like diuretics, MRA, Amiloride

Site of Action, Maximum Dose, Half-Life, Onset, Bioavailability,
Action, Maximum Dose ... #Comparison #Table ... #HalfLife #Dosing ... Loop #Thiazide #CHF ... #Cardiology #Management
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Conversions ... conversion that ... , CV benefits, renal ... #Table #Dosing ... #Pharmacology #Dose
Classification, Differential Diagnosis, and Features of Hyponatremia According to Volume Status 

Hypervolemic hypernatremia 
 - CHF
hypernatremia - CHF ... Glucocorticoid deficit - Hypokalemia ... Drugs - SIADH Renal ... Differential #Diagnosis #Table ... #Causes
Potassium-Binding Agents to Treat Hyperkalemia
Sodium zirconium cyclosilicate (Lokelma):
 • Mechanism: Preferentially captures K in exchange for
and sodium • Dosing ... 10 g QD (adjust dose ... g QD; increase dose ... #medications #pharmacology ... #table #comparison
Treatment of Stable Narrow-Complex Tachycardia
Regular Rhythm:
 • Attempt vagal maneuvers
 • Give adenosine 6 milligrams IV
Repeat 12-milligram dose ... disease or CHF) ... Treat underlying cause ... disease or CHF) ... Tachycardia #Treatment #management
Hyperkalemia - Diagnosis and Management - GrepMed Handbook

S/Sx: Most pts asymptomatic. Weakness, cramping, nausea, paresthesias, palpitations,
Na delivery): CHF ... 15 suggests ↓ renal ... only if no clear cause ... Elimination (see Table ... Transient, repeat dose
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
Doses should be ... potassium and renal ... ReceptorBlocker #Pharmacology ... #Conversion #Switching ... #Equivalent #Table
Pharmacologic Options for Hypercalcemia Associated with Cancer
Rehydration with NS followed by loop diuretics
 • IV normal
Pharmacologic Options ... for Hypercalcemia ... Inhibits vitamin D conversion ... #medications #management ... #table